Comparison of the side populations in pretreatment and postrelapse neuroblastoma cell lines

Translational Oncology

Volumn 3, Issue 4, 2010, Pages 246-251

  Newton, Thomas C ^a   Wolcott, Karen ^b   Roberts, Stephen S ^b  

^a KEESLER MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CHILD; COLONY FORMATION; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; NEUROBLASTOMA CELL; STEM CELL;

EID: 77955693585     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09301     Document Type: Article

References (42)

1. Maris JM, Hogarty MD, Bagatell R, and Cohn SL (2007). Neuroblastoma. Lancet 369, 2106-2120.
2. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, et al. (1999). Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341, 1165-1173.
3. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, and Villablanca JG (2009). Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Children's Oncology Group study. J Clin Oncol 27, 1007-1013.
4. Wu C and Alman BA (2008). Side population cells in human cancers. Cancer Lett 268, 1-9.
5. Hill RP (2006). Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66, 1891-1895; discussion 1890.
6. Kern SE and Shibata D (2007). The fuzzy math of solid tumor stem cells: a perspective. Cancer Res 67, 8985-8988.
7. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, and Brenner MK (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101, 14228-14233.
8. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, and Dick JE (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648.
9. Bonnet D and Dick JE (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737.
10. Al-Hajj M and Clarke MF (2004). Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282.
11. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, and Clarke MF (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988.
12. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, and Herlyn M (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65, 9328-9337.
13. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, and Dirks PB (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res 63, 5821-5828.
14. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
15. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD, et al. (2007). Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67, 11234-11243.
16. O'Brien CA, Pollett A, Gallinger S, and Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
17. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, and De Maria R (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115.
18. Ross RA and Spengler BA (2007). Human neuroblastoma stem cells. Semin Cancer Biol 17, 241-247.
19. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, et al. (2005). Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323-335.
20. Challen GA and Little MH (2006). A side order of stem cells: the SP phenotype. Stem Cells 24, 3-12.
21. Larderet G, Fortunel NO, Vaigot P, Cegalerba M, Maltere P, Zobiri O, Gidrol X, Waksman G, and Martin MT (2006). Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells 24, 965-974.
22. Majka SM, Beutz MA, Hagen M, Izzo AA, Voelkel N, and Helm KM (2005). Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells 23, 1073-1081.
23. Shimano K, Satake M, Okaya A, Kitanaka J, Kitanaka N, Takemura M, Sakagami M, Terada N, and Tsujimura T (2003). Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol 163, 3-9.
24. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, and Garry DJ (2004). Persistent expression of the ATPbinding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265, 262-275.
25. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, and Yamashita S (2007). Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148, 1797-1803.
26. Kondo T, Setoguchi T, and Taga T (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101, 781-786.
27. Ho MM, Ng AV, Lam S, and Hung JY (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67, 4827-4833.
28. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, and Mori M (2006). Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24, 506-513.
29. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, and Taniguchi H (2006). Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44, 240-251.
30. Wang J, Guo LP, Chen LZ, Zeng YX, and Lu SH (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67, 3716-3724.
31. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, and Donahoe PK (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103, 11154-11159.
32. Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS, and Alman BA (2007). Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 67, 8216-8222.
33. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7, 1028-1034.
34. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, and Ross RA (2004). Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6, 838-845.
35. Bez A, Corsini E, Curti D, Biggiogera M, Colombo A, Nicosia RF, Pagano SF, and Parati EA (2003). Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization. Brain Res 993, 18-29.
36. Islam MO, Kanemura Y, Tajria J, Mori H, Kobayashi S, Hara M, Yamasaki M, Okano H, and Miyake J (2005). Functional expression of ABCG2 transporter in human neural stem/progenitor cells. Neurosci Res 52, 75-82.
37. Thomas SK, Messam CA, Spengler BA, Biedler JL, and Ross RA (2004). Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279, 27994-27999.
38. Keshelava N, Seeger RC, Groshen S, and Reynolds CP (1998). Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res 58, 5396-5405.
39. Telford WG, Bradford J, Godfrey W, Robey RW, and Bates SE (2007). Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells 25, 1029-1036.
40. Chambers I and Tomlinson SR (2009). The transcriptional foundation of pluripotency. Development 136, 2311-2322.
41. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, and Looijenga LH (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211, 1-9.
42. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, and Tang DG (2009). Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27, 993-1005.